🇨🇦 DTacP-IPV combined vaccine (TETRAXIM™) in Canada

DTacP-IPV combined vaccine (TETRAXIM™) (DTacP-IPV combined vaccine (TETRAXIM™)) regulatory status in Canada.

Marketing authorisation

DTacP-IPV combined vaccine (TETRAXIM™) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Canada

Frequently asked questions

Is DTacP-IPV combined vaccine (TETRAXIM™) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for DTacP-IPV combined vaccine (TETRAXIM™) in Canada?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.